Chris Chaney

Accelus President & CEO Kevin McGann to Present at LSI USA '24 Conference

Retrieved on: 
Tuesday, March 5, 2024

McGann’s presentation will provide an unparalleled opportunity for industry participants to engage with the company.

Key Points: 
  • McGann’s presentation will provide an unparalleled opportunity for industry participants to engage with the company.
  • Accelus has made significant strides under McGann’s leadership, from the sale of its Remi spine robot to Alphatec for $55 million to its recent $20 million funding from Symbiotic Capital.
  • “The LSI USA ’24 conference presents a valuable opportunity for attendees to discover how Accelus’s advancements in expandable spinal implants are providing minimally invasive yet maximally effective solutions for spinal fusion,” McGann said.
  • Attendees of the LSI USA '24 conference are invited to join Kevin McGann's presentation on March 21st at 2:40 p.m. in Track 2 to learn more about Accelus's transformative technologies and strategic vision for the future of spine care.

Accelus Introduces LineSider Modular-Cortical System for Posterior Fixation

Retrieved on: 
Monday, January 29, 2024

This expansion to Accelus’s LineSider Spinal System product portfolio is designed to meet the needs of surgeons who use a modular pedicle screw system from either a standard open approach or a medial-to-lateral cortical approach.

Key Points: 
  • This expansion to Accelus’s LineSider Spinal System product portfolio is designed to meet the needs of surgeons who use a modular pedicle screw system from either a standard open approach or a medial-to-lateral cortical approach.
  • “I highly recommend utilizing the LineSider Modular-Cortical System to complement the FlareHawk expandable interbody fusion device,” said Dr. Ryan Martyn, orthopedic spine surgeon at Spine Colorado.
  • The LineSider Modular-Cortical System builds on Accelus's legacy of developing adaptable, surgeon-centric solutions.
  • "The LineSider Modular-Cortical System exemplifies our commitment to elevating the surgical experience and improving patient outcomes,” said Accelus President and Chief Executive Officer Kevin McGann.

Jimmy's Jazz & Blues Club Features 2x-GRAMMY® Award Nominee, 6x-Blues Music Award-Winner & Iconic Blues Guitarist and Singer DUKE ROBILLARD on Sunday February 25 at 7:30 P.M.

Retrieved on: 
Wednesday, January 24, 2024

PORTSMOUTH, N.H., Jan. 24, 2024 /PRNewswire/ -- Jimmy's Jazz & Blues Club Features 2x-GRAMMY® Award Nominee, 6x-Blues Music Award-Winner, 22x-Blues Music Award Nominee & Iconic Blues Guitarist and Singer DUKE ROBILLARD and his Acclaimed Band on Sunday February 25 at 7:30 P.M. Duke Robillard will render any song with mastery, power, nuance and an unerring grasp of its essence. Duke has carved out one of blues' most illustrious legacies, while also crossing some lofty related territories as a Guitarist, Vocalist, Songwriter, Bandleader, and Producer.

Key Points: 
  • PORTSMOUTH, N.H., Jan. 24, 2024 /PRNewswire/ -- Jimmy's Jazz & Blues Club Features 2x-GRAMMY® Award Nominee, 6x-Blues Music Award-Winner, 22x-Blues Music Award Nominee & Iconic Blues Guitarist and Singer DUKE ROBILLARD and his Acclaimed Band on Sunday February 25 at 7:30 P.M. Duke Robillard will render any song with mastery, power, nuance and an unerring grasp of its essence.
  • Duke has carved out one of blues' most illustrious legacies, while also crossing some lofty related territories as a Guitarist, Vocalist, Songwriter, Bandleader, and Producer.
  • "Since Robillard helped found Roomful of Blues in the 1960s, he has been the leading torch-bearer for this vibrant music that eventually morphed into rock-and-roll.
  • After showing an early affinity for music and guitar, DUKE ROBILLARD founded Roomful of Blues with pianist Al Copley in Westerly, R.I., in 1967.

Accelus Sells Remi Robotic Navigation System to Alphatec and Announces Leadership Change to Drive Growth and Innovation

Retrieved on: 
Wednesday, April 19, 2023

The capital provided by the sale of the Remi technology will allow Accelus to invest internally, helping the company to improve its offerings more rapidly for both minimally invasive and endoscopic spine surgery.

Key Points: 
  • The capital provided by the sale of the Remi technology will allow Accelus to invest internally, helping the company to improve its offerings more rapidly for both minimally invasive and endoscopic spine surgery.
  • The company also plans to streamline its operations to optimize efficiency, reduce costs and enhance its ability to deliver value to customers.
  • This focus on profitability will enable the company to continue to invest in innovation and grow the business over the long term.
  • Integrity Implants also holds FDA clearances for its LineSider Spinal System pedicle screws and Toro-L Interbody Fusion System, which is currently in an alpha launch phase.